Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

424
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
424
Cross-reactivity00:42

Cross-reactivity

31.8K
Overview
31.8K
Cancer Vaccines01:30

Cancer Vaccines

570
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
570
Vaccinations01:51

Vaccinations

46.7K
Overview
46.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Redefining Drug Immune Recognition: A Radically Reconfigured Molecular Architecture Enables Broad Fentanyl-Class Protection.

Journal of medicinal chemistry·2026
Same author

Fentanyl-Rewired: A 2‑Azaspiro[3.3]heptane Core Preserves μ‑Opioid Function.

ACS medicinal chemistry letters·2026
Same author

Bifunctional Behavior of Conformationally Constrained Methamphetamine Analogs: Unexpected Heteroclitic Immune Response and Antagonist Effects Altering Methamphetamine and Fentanyl Pharmacology.

Journal of medicinal chemistry·2025
Same author

Bifunctional Inhibition of Botulinum Neurotoxin A Protease: Unexpected Active Site Inhibition Enhances Covalent Targeting of an Allosteric Site.

Journal of medicinal chemistry·2025
Same author

Investigations of Thiosemicarbazides as Botulinum Toxin Active-Site Inhibitors: Enzyme, Cellular, and Rodent Intoxication Studies.

ACS infectious diseases·2024
Same author

Genetic or pharmacological GHSR blockade has sexually dimorphic effects in rodents on a high-fat diet.

Communications biology·2024

Related Experiment Video

Updated: Oct 22, 2025

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

3.8K

Broadly Neutralizing Synthetic Cannabinoid Vaccines.

Mingliang Lin1, Jinny Claire Lee1, Steven Blake1

  • 1Department of Chemistry, Department of Immunology and Microbial Science, The Skaggs Institute for Chemical Biology, and The Worm Institute for Research and Medicine (WIRM), The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States.

JACS Au
|September 1, 2021
PubMed
Summary

This study developed novel vaccine strategies against synthetic cannabinoids (SCs) by designing haptens for antibody generation. Promising vaccine candidates effectively neutralized multiple SCs in animal models, offering a new approach to combatting cannabinoid use disorder.

More Related Videos

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.7K
Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
10:17

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library

Published on: January 14, 2020

8.0K

Related Experiment Videos

Last Updated: Oct 22, 2025

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

3.8K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.7K
Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
10:17

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library

Published on: January 14, 2020

8.0K

Area of Science:

  • Pharmacology
  • Immunology
  • Drug Development

Background:

  • Synthetic cannabinoids (SCs) pose a significant public health risk due to their widespread use and diverse chemical structures.
  • Developing effective countermeasures against SCs is crucial for addressing cannabinoid use disorder.

Purpose of the Study:

  • To design and screen haptens for generating broadly neutralizing antibodies against synthetic cannabinoids.
  • To evaluate the efficacy of developed vaccines in preclinical animal models.
  • To explore combination vaccine approaches for broader SC coverage.

Main Methods:

  • Screening of 10 different hapten designs for antibody affinity and cross-reactivity against 22 synthetic cannabinoids.
  • Assessment of vaccine efficacy in animal models by monitoring locomotion, body temperature, and pharmacokinetics after SC administration (vaping and intraperitoneal injection).
  • Investigation of synergistic effects using an admixture vaccine approach targeting multiple SC classes.

Main Results:

  • Three vaccine groups demonstrated submicromolar IC50 values, with each targeting 5-6 different SCs.
  • Successful sequestration of SCs was confirmed in animal models following different administration routes.
  • Synergistic effects were observed, enabling simultaneous neutralization of two drug classes with an admixture vaccine.

Conclusions:

  • The study provides a robust foundation for developing active immunization strategies against synthetic cannabinoids.
  • Optimized hapten design and combination vaccine approaches show significant potential for combating synthetic cannabinoid use disorder.
  • These findings pave the way for novel therapeutic vaccines targeting a wide range of psychoactive substances.